共 24 条
[1]
Hirsh J., Dalen J., Anderson D.R., Poller L., Bussey H., Ansell J., Deykin D., Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range, Chest, 119, (2001)
[2]
Hirsh J., Dalen J., Guyatt G., The sixth (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis, Chest, 119, (2001)
[3]
Palmer R.N., Kessler C.M., Gralnick H.R., Warfarin anticoagulation: Difficulties in interpretation of the prothrombin time, Thromb. Res., 25, pp. 125-130, (1982)
[4]
D'Angelo A., Della V.P., Crippa L., Fattorini A., Pattarini E., Vigano D.S., Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo pro-thrombin activation during the early and steady phases of oral anticoagulant treatment, Haematologica, 87, pp. 1074-1080, (2002)
[5]
Tripodi A., Cattaneo M., Molteni A., Cesana B.M., Mannucci P.M., Changes of prothrombin fragment 1+2 (F 1+2) as a function of increasing intensity of oral anticoagulation - Considerations on the suitability of F 1+2 to monitor oral anticoagulant treatment, Thromb. Haemost., 79, pp. 571-573, (1998)
[6]
Koefoed B.G., Feddersen C., Gullov A.L., Petersen P., Effect of fixed minidose warfarin, conventional dose warfarin and aspirin on INR and prothrombin fragment 1 + 2 in patients with atrial fibrillation, Thromb. Haemost., 77, pp. 845-848, (1997)
[7]
Bruhn H.D., Conard J., Mannucci M., Monteagudo J., Pelzer H., Reverter J.C., Samama M., Tripodi A., Wagner C., Multicentric evaluation of a new assay for prothrombin fragment F1+2 determination, Thromb. Haemost., 68, pp. 413-417, (1992)
[8]
Lind S.E., Callas P.W., Golden E.A., Joyner Jr. K.A., Ortel T.L., Plasma levels of factors II, VII and X and their relationship to the international normalized ratio during chronic warfarin therapy, Blood Coagul. Fibrinolysis, 8, pp. 48-53, (1997)
[9]
Weinstock D.M., Chang P., Aronson D.L., Kessler C.M., Comparison of plasma prothrombin and factor VII and urine prothrombin F1 concentrations in patients on long-term warfarin therapy and those in the initial phase, Am. J. Hematol., 57, pp. 193-199, (1998)
[10]
De Muth J.E., Basic statistics and pharmaceutical statistical applications, (1999)